2385. Ceftazidime–Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa

BACKGROUND: By targeting penicillin binding protein-3, the AmpC β-lactamase, and MurA, another enzyme involved in cell wall synthesis, with the ceftazidime–avibactam–fosfomycin combination, we previously overcame multidrug resistance (MDR) in vitro in an archived collection of Pseudomonas aeruginosa...

Descripción completa

Detalles Bibliográficos
Autores principales: Papp-Wallace, Krisztina M, Zeiser, Elise T, Becka, Scott A, Park, Steven T, Winkler, Marisa L, Nguyen, Kevin, Singh, Indresh, Sutton, Granger, Fouts, Derrick E, Ellis-Grosse, Evelyn J, Drusano, George L, Perlin, David S, Bonomo, Robert A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253269/
http://dx.doi.org/10.1093/ofid/ofy210.2038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253269/
http://dx.doi.org/10.1093/ofid/ofy210.2038

Ejemplares similares